Results 181 to 190 of about 129,108 (303)
Myocardial protection during heart transplantation using blood cardioplegia
Preliminary results with a novel technique of myocardial protection for heart ...
Chiominto B. +5 more
core
CYP2C19 and CYP3A4 contribute to clopidogrel bioactivation. CYP2C19 no‐function alleles diminish clopidogrel's antiplatelet effects and clinical effectiveness. Coadministration of either a CYP2C19 or a CYP3A4 inhibitor may also reduce clopidogrel's antiplatelet effects and lead to phenoconversion in patients without a CYP2C19 no‐function allele (normal/
Danwei Shao +8 more
wiley +1 more source
Myocardial protection by adenosine triphosphate-sensitive potassium channel opener diazoxide involves sulfonylurea receptor 2 subunit. [PDF]
Wang J +6 more
europepmc +1 more source
Effects of swimming training on myocardial protection in rats. [PDF]
Lai CC +4 more
europepmc +1 more source
This review synthesizes advances in predicting miners' vital signs by integrating environmental monitoring (dust, temperature, and gas) with physiological data. It highlights multi‐source data fusion techniques and early‐warning models for enhanced occupational safety in underground coal mines.
Junji Zhu +4 more
wiley +1 more source
Comparison of the effect of cardioplegic solutions used in cardiac surgery on myocardial protection. [PDF]
Padak M, Dikme R, Ersöz E, Hacanlı Y.
europepmc +1 more source
Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice. [PDF]
Peng L +14 more
europepmc +1 more source
Abstract Background The zebrafish heart regenerates upon injury. During injury response, fibroblasts and endothelial cells accumulate at the site of damage, and cardiomyocyte cell cycle reentry allows cardiac muscle regrowth. It is relevant to understand how the different cell types communicate with each other to coordinate regeneration.
João A. S. Carvalho +6 more
wiley +1 more source
Correction: Blood cardioplegia or custodiol for myocardial protection during valvular or aortic surgery: a propensity score adjusted comparison. [PDF]
Carnero-Alcazar M +9 more
europepmc +1 more source
Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost. [PDF]
Efentakis P +6 more
europepmc +1 more source

